What you'll receive
You'll receive a scholarship, of $40,000 per annum, indexed annually for 3 years, with the possibility of up to 1 year extension.
The successful applicant will be required to apply for externally competitive scholarships during his/her candidature. A clinical loading may be negotiated.
You must have:
- completed an undergraduate degree in medicine
- be registered as a medical practitioner with the Australian Health Practitioners Regulatory Authority (AHPRA)
- have relevant post-graduate clinical experience and training in obstetrics and gynaecology and/or paediatrics
- a commitment to the health of First Nations peoples.
Aboriginal, Torres Strait Islander, Maori and/or Pacific Islander people are strongly encouraged to apply.
How to apply
- a cover letter
- an up-to-date CV
- a full academic transcript
- a summary (up to 2 pages) of your career outlining your clinical and research experience
- details of 3 referees (email, address and contact number)
If your expression of interest is accepted you will then need to formally submit your application for admission.
What happens next?
About the scholarship
The Cough, Asthma and Airways Research Group (CAARG) in the School of Public Health and Social Work and Institute of Health & Biomedical Innovation at QUT is seeking a medical degree graduate to undertake a PhD within a randomised controlled trial of a vaccine given in pregnancy and its role in preventing infant illnesses in the first 12 months of life (The PneuMatters Study).
The trial is funded by the National Health and Medical Research Council.
This PhD offers the opportunity to work with an internationally recognised team of clinicians, epidemiologists, medical scientists and others on a multi-centre-randomised controlled trial that addresses both maternal and child health in First Nations peoples. The successful candidate will be located at the Centre for Children’s Health Research in South Brisbane under the supervision of Professor Anne B Chang and Dr Kerry-Ann O’Grady. Other external supervisors may be engaged. The research is a collaboration with clinicians and researchers from:
- Menzies School of Health Research
- The University of Queensland
- Griffith University
- Sydney University
- The University of Malaya
- Royal Darwin Hospital
- Logan Hospital
- The Toowoomba Hospital
- Royal Brisbane Hospital
- Nganampa Health Council
- Likas Hospital in Malaysia.
The trial incorporates clinical, immunological, microbiological and safety endpoints.